170 related articles for article (PubMed ID: 17292394)
1. Mechanistic basis for the pathogenesis of long QT syndrome associated with a common splicing mutation in KCNQ1 gene.
Tsuji K; Akao M; Ishii TM; Ohno S; Makiyama T; Takenaka K; Doi T; Haruna Y; Yoshida H; Nakashima T; Kita T; Horie M
J Mol Cell Cardiol; 2007 Mar; 42(3):662-9. PubMed ID: 17292394
[TBL] [Abstract][Full Text] [Related]
2. Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus.
Yamashita F; Horie M; Kubota T; Yoshida H; Yumoto Y; Kobori A; Ninomiya T; Kono Y; Haruna T; Tsuji K; Washizuka T; Takano M; Otani H; Sasayama S; Aizawa Y
J Mol Cell Cardiol; 2001 Feb; 33(2):197-207. PubMed ID: 11162126
[TBL] [Abstract][Full Text] [Related]
3. Clinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome.
Yamaguchi M; Shimizu M; Ino H; Terai H; Hayashi K; Mabuchi H; Hoshi N; Higashida H
Clin Sci (Lond); 2003 Apr; 104(4):377-82. PubMed ID: 12653681
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of KCNQ1 mutations around the exon 7-intron 7 junction affecting the splicing process.
Tsuji-Wakisaka K; Akao M; Ishii TM; Ashihara T; Makiyama T; Ohno S; Toyoda F; Dochi K; Matsuura H; Horie M
Biochim Biophys Acta; 2011 Nov; 1812(11):1452-9. PubMed ID: 21810471
[TBL] [Abstract][Full Text] [Related]
5. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
[TBL] [Abstract][Full Text] [Related]
6. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
[TBL] [Abstract][Full Text] [Related]
7. A double-point mutation in the selectivity filter site of the KCNQ1 potassium channel results in a severe phenotype, LQT1, of long QT syndrome.
Ikrar T; Hanawa H; Watanabe H; Okada S; Aizawa Y; Ramadan MM; Komura S; Yamashita F; Chinushi M; Aizawa Y
J Cardiovasc Electrophysiol; 2008 May; 19(5):541-9. PubMed ID: 18266681
[TBL] [Abstract][Full Text] [Related]
8. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
[TBL] [Abstract][Full Text] [Related]
9. The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes.
Li W; Du R; Wang QF; Tian L; Yang JG; Song ZF
Biochem Biophys Res Commun; 2009 May; 383(2):206-9. PubMed ID: 19348785
[TBL] [Abstract][Full Text] [Related]
10. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
[TBL] [Abstract][Full Text] [Related]
11. [The mutation scanning of KCNQ1 gene for 31 long QT syndrome families].
Li P; Li CL; Hu DY; Liu WL; Qin XG; Li YT; Li ZM; Li L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):236-9. PubMed ID: 15192825
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal juxtamembranous domain of KCNQ1 is critical for channel surface expression: implications in the Romano-Ward LQT1 syndrome.
Dahimène S; Alcoléa S; Naud P; Jourdon P; Escande D; Brasseur R; Thomas A; Baró I; Mérot J
Circ Res; 2006 Nov; 99(10):1076-83. PubMed ID: 17053194
[TBL] [Abstract][Full Text] [Related]
13. A hydrophobicity-dependent motif responsible for surface expression of cardiac potassium channel.
Pan N; Sun J; Lv C; Li H; Ding J
Cell Signal; 2009 Feb; 21(2):349-55. PubMed ID: 19041715
[TBL] [Abstract][Full Text] [Related]
14. New KCNQ1 mutations leading to haploinsufficiency in a general population; Defective trafficking of a KvLQT1 mutant.
Gouas L; Bellocq C; Berthet M; Potet F; Demolombe S; Forhan A; Lescasse R; Simon F; Balkau B; Denjoy I; Hainque B; Baró I; Guicheney P;
Cardiovasc Res; 2004 Jul; 63(1):60-8. PubMed ID: 15194462
[TBL] [Abstract][Full Text] [Related]
15. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1.
Thomas D; Khalil M; Alter M; Schweizer PA; Karle CA; Wimmer AB; Licka M; Katus HA; Koenen M; Ulmer HE; Zehelein J
J Mol Cell Cardiol; 2010 Jan; 48(1):230-7. PubMed ID: 19540844
[TBL] [Abstract][Full Text] [Related]
17. Abnormal KCNQ1 trafficking influences disease pathogenesis in hereditary long QT syndromes (LQT1).
Wilson AJ; Quinn KV; Graves FM; Bitner-Glindzicz M; Tinker A
Cardiovasc Res; 2005 Aug; 67(3):476-86. PubMed ID: 15935335
[TBL] [Abstract][Full Text] [Related]
18. An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome.
Bhuiyan ZA; Momenah TS; Amin AS; Al-Khadra AS; Alders M; Wilde AA; Mannens MM
Prog Biophys Mol Biol; 2008; 98(2-3):319-27. PubMed ID: 19027783
[TBL] [Abstract][Full Text] [Related]
19. Congenital long QT syndrome caused by the F275S KCNQ1 mutation: mechanism of impaired channel function.
Li W; Wang QF; Du R; Xu QM; Ke QM; Wang B; Chen XL; Tian L; Zhang SY; Kang CL; Guan SM; Yang JG; Song ZF
Biochem Biophys Res Commun; 2009 Feb; 380(1):127-31. PubMed ID: 19167356
[TBL] [Abstract][Full Text] [Related]
20. Isoproterenol exacerbates a long QT phenotype in Kcnq1-deficient neonatal mice: possible roles for human-like Kcnq1 isoform 1 and slow delayed rectifier K+ current.
Knollmann BC; Casimiro MC; Katchman AN; Sirenko SG; Schober T; Rong Q; Pfeifer K; Ebert SN
J Pharmacol Exp Ther; 2004 Jul; 310(1):311-8. PubMed ID: 15004216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
